SCHEMBL28249226

SCHEMBL28249226

CNC1CCN(CC2CC2)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.39
HRH3 Q9Y5N1 3/20 0.37
HRH2 P25021 1/20 0.37
HRH1 P35367 1/20 0.37
CHRM5 P08912 1/20 0.35
ADRA2C P18825 1/20 0.35
HRH4 Q9H3N8 6/20 0.35
KCNH2 Q12809 2/20 0.35
SCN1A P35498 1/20 0.34
SCN4A P35499 1/20 0.34
SCN7A Q01118 1/20 0.34
SCN5A Q14524 1/20 0.34
SCN9A Q15858 1/20 0.34
SCN2A Q99250 1/20 0.34
SCN3A Q9NY46 1/20 0.34
SCN11A Q9UI33 1/20 0.34
SCN8A Q9UQD0 1/20 0.34
SCN10A Q9Y5Y9 1/20 0.34
SIGMAR1 Q99720 1/20 0.33
JAK2 O60674 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13874822 0.92 ACHE (0.50) ACHEHRH3HRH2HRH1CHRM5
SCHEMBL23507480 0.89 NCF1 (0.39) ACHEHRH3HRH2HRH1CHRM5
SCHEMBL23507248 0.87 GBA1 (0.40) ACHEHRH3HRH2HRH1
SCHEMBL23507561 0.87 GBA1 (0.41) ACHEHRH3HRH2HRH1CHRM5
SCHEMBL23507523 0.87 GBA1 (0.41) ACHEHRH3HRH2HRH1CHRM5
SCHEMBL2842528 0.87 ACHE (0.47) ACHECHRM5ADRA2C
SCHEMBL22703769 0.81 ACHE (0.47) ACHECHRM5ADRA2CKCNH2SCN1A
SCHEMBL13874596 0.79 ACHE (0.59) ACHECHRM5ADRA2C
SCHEMBL2549878 0.78
SCHEMBL15079109 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022226668-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2022-11-03 WO disclosed
CN-108727343-A Quinazolinones PARP-1/2 inhibitor containing 3- amino nafoxidines and preparation method thereof, pharmaceutical composition and purposes 中国医学科学院药物研究所 2018-11-02 CN disclosed